Latest Commercialization News

Page 23 of 446
SKS Technologies Group has upgraded its FY26 earnings forecast following $60 million in new contract awards, including major projects for NEXTDC and Ernst & Young. The company anticipates stronger revenue and profit margins driven by robust demand in data centre infrastructure.
Sophie Babbage
Sophie Babbage
5 Feb 2026
Beach Energy’s FY26 half-year results reveal steady sales volumes and a robust ramp-up at the Waitsia Gas Plant, supported by strong LNG cargo revenues and disciplined cost management.
Maxwell Dee
Maxwell Dee
5 Feb 2026
Maas Group Holdings is selling its Construction Materials division for $1.7 billion to Heidelberg Materials Australia, marking a strategic pivot towards electrification, digital infrastructure, and AI-led growth.
Victor Sage
Victor Sage
5 Feb 2026
Maas Group Holdings has agreed to sell its Construction Materials division for up to $1.703 billion, marking a strategic pivot towards digital infrastructure and electrification sectors. The deal, expected to close in late 2026, includes a significant minority investment in AI infrastructure developer Firmus Grid.
Victor Sage
Victor Sage
5 Feb 2026
BCAL Diagnostics has launched its Avantect blood tests for pancreatic and ovarian cancer with encouraging early uptake and is advancing its BREASTESTplus breast cancer test towards broader clinical use.
Ada Torres
Ada Torres
5 Feb 2026
Prairie Lithium has retracted its previous production target citing compliance issues, while announcing a binding offtake agreement with South Korea’s Hydro Lithium for its Phase 1 lithium output. This move signals a strategic shift towards selling intermediate lithium products to reduce costs and accelerate market entry.
Maxwell Dee
Maxwell Dee
5 Feb 2026
Klevo Rewards Limited’s subsidiary Fly Wallet has secured key Mastercard compliance and earned over AUD 550,000 in incentives, marking a significant step in its payments platform evolution.
Claire Turing
Claire Turing
5 Feb 2026
The US Congress has reauthorized the Rare Pediatric Disease Priority Review Voucher program through September 2029, a move that could significantly benefit Neuren Pharmaceuticals as it advances its rare disease drug candidates.
Ada Torres
Ada Torres
5 Feb 2026
Evolution Trustees has appointed LDR Capital as the new manager of Elanor Commercial Property Fund following the termination of previous management agreements with Elanor Asset Services.
Eva Park
Eva Park
4 Feb 2026
Elanor Investors Group has ended its management role in the Elanor Commercial Property Fund following a securityholder vote, receiving $8.5 million in compensation as the fund transitions to new leadership.
Eva Park
Eva Park
4 Feb 2026
Elanor Commercial Property Fund members have voted to replace Elanor Funds Management Limited with Evolution Trustees Limited as the responsible entity, marking a significant governance shift now officially recorded by ASIC.
Eva Park
Eva Park
4 Feb 2026
ADX Energy has revealed a significant technical update on its Welchau appraisal permit in Austria, highlighting a connected petroleum system with 18 million barrels of prospective light oil and 125 billion cubic feet of gas condensate resources.
Maxwell Dee
Maxwell Dee
4 Feb 2026